article thumbnail

The ‘Great Retraining’: IT upskills for the future

CIO

It’s a win-win when you can get the long-term vision and growth of a company tied to individual career and professional development,” says Mark Yunger, vice president, head of IT at Servier Pharmaceuticals. From an individual’s perspective, it keeps careers interesting and helps people grow with the organization.

article thumbnail

Women IT leaders take center stage

CIO

Cultivating visibility matters for a few reasons,” says Kathryn Guarini, a former IBM CIO and now a board member at Regeneron Pharmaceuticals. Kathryn Guarini, board member, Regeneron Pharmaceuticals, and former IBM CIO Guarini “You want to be the one considered for opportunities to have an impact,” she says.

IT 659
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment

ArchIntel

pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. pharmaceutical and health care industry’s more notable CI executives. ArchIntel™ -.

article thumbnail

Can developer productivity be measured? Better than you think

CIO

The developer productivity metrics that matter most The reason we believe this is that we are working with 20 tech, finance, and pharmaceutical companies that are doing it. The results are not definitive, but they are promising. Here’s how it works.

article thumbnail

J&J’s Jim Swanson brings mission-driven leadership to the CIO role

CIO

He started out as a scientist, working his way up the research and development ranks in the pharmaceutical industry, an experience steeped in curiosity that has helped shape his emphasis on continuous learning to this day.

article thumbnail

The Evolution of Pharma Market Research

Alpha Sense BI

The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. By taking a more proactive—rather than reactive—approach to research, organizations can leverage better-informed strategies to stay ahead of their competitors.

article thumbnail

Industry clouds prove their business value

CIO

Perhaps most important, Idorsia taps into Veeva’s evolving knowledge base, which encompasses data from other customers such as major pharmaceuticals giants Merck, Bayer, and Kronos, the CIO says. It’s better to go with an industry cloud because you inherit what research work the industry cloud provider has,” he says.